Bio-techne boosts antibody portfolio with $60m Novus acq
Protein manufacturer Bio-Techne has expanded its purified proteins portfolio through the $60m (€44m) acquisition of antibody developer Novus Biologicals.
Archives for July 8, 2014
60-year old smallpox found in US FDA lab may still be viable, if only live vaccines lasted as long
For live vaccine manufacturers working to extend shelf-life, the discovery that 60-year old smallpox virus found at a US Food and Drug Administration (FDA) lab could still be viable will be as galling as it is worrying.
Fourth times the charm? Abbvie re-ups offer to buy Shire for £30bn
AbbVie has once again raised its bid to purchase Shire – this time by about 11% to £30.1bn ($51bn).